traccs.net 的前十大競爭對手

amiculum.biz

Amiculum supports Lung Cancer Europe’s ‘Get Checked!’ campaign for Lung Cancer Awareness Month

sandpipercomms.com

Innovative drugs and devices are being made more accessible in general across the region, while public healthcare coverage differs substantially from country to country, giving rise to a range of hybrid, multi-payment systems and different types of public-private partnerships. This poses great opportunity, but also challenges, for drug and device manufacturers, as well as healthcare providers – and especially healthcare communicators.

pressreach.com

TORONTO, May 28, 2026 - Mayfair Gold Corp. ("Mayfair", "Mayfair Gold", or the "Company") (TSXV:MFG) (NYSE American: MINE) is pleased to announce the

getthewordout.com.au

Sydney, Australia – The Australian adventure and outdoor industry will come together once again as the Australian Adventure Expo returns to Sydney Showground, Sydney Olympic Park, 21-22 October 2026. As Australia’s premier trade expo for the sector, the Australian Adventure Expo (AAE) attracts a highly targeted trade audience, bringing together manufacturers, distributors and service providers […]

newmediawire.com

LOS ANGELES, CA - January 9, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) was among the medical device companies highlighted in a Jan. 8 report by Modern Healthcare by Lauren Dubinsky that outlined FDA clearances and approvals across the medical device sector. HeartBeam’s 12-lead electrocardiogram synthesis software was cleared Dec. 8 to assess arrhythmias by converting heart signal data captured from 3 dimensions using the company’s portable, non-invasive recorder into a standard 12-lead ECG format suitable for remote clinical review. HeartBeam recently reinforced its technology leadership with recognition as a Global IP and Technology Leader in Portable Cardiac Diagnostics, ranking second worldwide and trailing only GE Healthcare, in 12-lead ECG innovation among 243 companies evaluated in PatentVest’s “Total Cardiac Intelligence” report, according to an InvestorBrandNetwork report. The ranking reflects the strength of its intellectual-property foundation, with 82 global patent publications across 15 patent families supporting its three-dimensional cardiac signal capture and 12-lead ECG synthesis architecture, underscoring the company’s growing influence in next-generation remote cardiac monitoring. To learn more about Heartbeam’s Portable ECG Technology, visit https://ibn.fm/pfPB1 About HeartBeam, Inc. HeartBeam, Inc. is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first-ever cable-free device capable of collecting ECG signals in 3D, from three non-coplanar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health manageme

web3newswire.com

Web3 Newswire is a leading crypto press release distribution platform helping blockchain startups gain exposure across major Web3 and Crypto news outlets.

diffusionpr.com

From smart homes and intelligent energy systems to sustainable mobility and personalised wellness, Purpose Technology is transforming how we, our families, and our communities live, move, and care for the world around them.

institutclimatique.ca

Le leadership autochtone dans les projets de transport d'électricité est essentiel à la transition énergétique. Bien que le ...

sphs.indiana.edu

Learn about our services to facilitate improved cognitive and communication skills.